SyntheticMR Q1 net sales fall 8% on lower OEM sales in Europe, North America

Syntheticmr publ AB

12/05/2026 07:21

Overview

Sweden neuroimaging software firm's Q1 net sales fell 8% on lower OEM sales in Europe, North America

Q1 net loss narrowed from prior year as cost-saving measures reduced expenses

Company highlighted regulatory approvals and new strategic partnerships during the quarter

Outlook

Company aims to return to profitability through recurring revenue and cost control

SyntheticMR plans to strengthen commercial capabilities and expand OEM collaborations in 2026

Company expects further product launches with OEM partners in 2027/28

Result Drivers

LOWER OEM SALES - Company said Q1 sales decline was mainly due to lower OEM sales in Europe and North America

WEAK JAPAN DEMAND - Developments in Japan have been negatively affected by the current economic environment, leading to increased caution in investments

COST SAVINGS - Costs decreased 16.5% from a year earlier, mainly due to cost-saving measures implemented at the beginning of 2025 and continued cost discipline

Company press release: ID:nWkr6R2pwX

Key Details

Metric
Beat/Miss
Actual
Consensus Estimate
Q1 Sales
SEK 13.1 mln
SEK 15 mln (1 Analyst)
Q1 Net Income
-SEK 6.2 mln
Q1 Operating Profit
-SEK 6.3 mln


Analyst Coverage

The current average analyst rating on the shares is "hold" and the breakdown of recommendations is no "strong buy" or "buy", 2 "hold" and no "sell" or "strong sell"

The average consensus recommendation for the advanced medical equipment & technology peer group is "buy."

Wall Street's median 12-month price target for Syntheticmr publ AB is SEK1.16, about 7.4% above its May 11 closing price of SEK1.08

For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact reuters.support@thomsonreuters.com.

(This story was created using Reuters automation and AI based on LSEG and company data. It was checked and edited by a Reuters journalist prior to publication.)